TrialBMC pharmacology & toxicology2016

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).

Nikolaj Kunøe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.